Modulation of Immunity by Hormonal Contraceptives
NCT02011711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2017-01-16
Summary
Clinical study to determine if hormonal contraceptive use effects cells that fight infection (i.e., immune cells).
Conditions
- Contraception
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
Thomas L. Cherpes
lead OTHER
Principal Investigators
-
Thomas L Cherpes, MD · Stanford University
Eligibility
- Min Age
- 15 Years
- Max Age
- 25 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- United States
Study Locations
More Related Trials
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED
-
Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age
NCT06918873 ·Status: RECRUITING
-
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
NCT00128726 ·Status: COMPLETED
-
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
NCT00781456 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Baricitinib and Birth Control Pills in Healthy Females
NCT01896726 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Contraceptive Consumption Timing and Cognition and Metabolism
NCT06560944 ·Status: COMPLETED ·Phase: NA
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
Myocardial Infarction and Current Oral Contraceptive Use
NCT00005241 ·Status: COMPLETED
-
Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases
NCT01469585 ·Status: COMPLETED ·Phase: NA
-
Mirena Efficiency and Tolerability During the First Year of Use
NCT00696202 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
NCT01953211 ·Status: COMPLETED
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
NCT00508911 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
NCT05683119 ·Status: RECRUITING ·Phase: NA
-
Impact of Oral Contraceptives on GABA and Neurosteroids
NCT00656318 ·Status: TERMINATED
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.
NCT06535698 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
NCT02269241 ·Status: COMPLETED ·Phase: PHASE3
-
Myocardial Infarction and Past Oral Contraceptive Use
NCT00005173 ·Status: COMPLETED
-
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
NCT00089414 ·Status: TERMINATED ·Phase: PHASE2